Assessing need for medication-assisted treatment for opiate-dependent prison inmates

Substance Abuse

Volumn 33, Issue 1, 2012, Pages 60-69

  Albizu García, Carmen E ^a   Caraballo, José Noel ^b   Caraballo Correa, Glorimar ^a   Hernández Viver, Adriana ^a   Román Badenas, Luis ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b UNIVERSITY OF PUERTO RICO AT CAYEY   (Puerto Rico)

Author keywords

drug abuse treatment; Inmates; medication assisted treatment; needs assessment; prisons

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HEALTH SERVICE; HEROIN DEPENDENCE; HUMAN; MALE; NEEDS ASSESSMENT; OPIATE SUBSTITUTION TREATMENT; PRISONER; PUERTO RICO;

ADULT; ANALGESICS, OPIOID; BUPRENORPHINE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; NEEDS ASSESSMENT; OPIATE SUBSTITUTION TREATMENT; PRISONERS; PUERTO RICO; YOUNG ADULT;

EID: 84856867478     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2011.620462     Document Type: Article

References (29)

1. Office of National Drug Control Policy. Heroin facts & figures. 2010. Available at: http://www.whitehousedrugpolicy.gov/drugfact/heroin/heroin ff.html#go4. Accessed March 12, 2010.
2. National Quality Forum (NQF). National Voluntary Consensus Standards for the Treatment of Substance Use Conditions: Evidence-Based Treatment Practice.Washington, DC: National Quality Forum; 2007.
3. United Nations Office on Drugs and Crime/World Health Organization (UNODC/WHO). HIV/AIDS Prevention Care, Treatment and Support in Prision Setting. A Framework for and Effective National Response. Geneva, UNODC/WHO; 2006.
4. Brown BS, Needle RH. Modifying the process of treatment to meet the threat of AIDS. Int J Addict. 1994;29:1739-1752.
5. Inciardi JA, McBride DC, Surratt HS. The heroin street addict: profiling a national population. In: Inciardi JA, Harrison L, eds. Heroin in the Age of Crack-Cocaine. Thousand Oaks, CA: Sage Publications; 1998:31-50.
6. Smith-Rohrberg D, Bruce RD, Altice FL. Research note-reviewof correction-based therapy for opiatedependent patient: implications for buprenorphine treatment among correctional populations. J Drug Issues. 2004;34:451-480.
7. McLellan AT, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284:1689-1695.
8. Kerr T, Jürgens R. Methadone maintenance therapy in prisons: reviewing the evidence. Canadian HIV/AIDS Legal Network Web site. 2004. Available at: http://www.aidslaw.ca/home.htm. Accessed February 22,2006.
9. Heimer R, Catania H, Newman RG, Zambrano J, Brunet A, Ortiz AM. Methadone maintenance in prison: evaluation of a pilot program in Puerto Rico. Drug Alcohol Depend. 2006;83:122-129.
10. PereiraM. Tres visiones: un solo panorama. Una descripci ón critica de la adicción desde la perspectiva política, salubrista y de la rehabilitación. In: Plenaria, Primer seminario prevención de sobredosis: Introducción al modelo SKOOP. San Juan, Puerto Rico: Hospital San Juan Capestrano; 29 de octubre de 2005.
11. Brown BS. Program models. NIDA Res Monogr. 1992;118:31-37.
12. National Mental Health Development Unit. Joint Strategic Needs Assessment and Mental Health Commissioning Toolkit. A Practical Guide. England: NationalMental Health, Development Unit; 2009.
13. Rush B. A systems approach to estimating the required capacity of alcohol treatment services. Br J Addict. 1990;85:49-59.
14. Friedman SR, Cooper HL, Tempalski B, Keem M, Friedman R, Flom PL. Relationship of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS. 2006;20:93-99.
15. Mears DP. Drug Treatment in the Criminal Justice System: The Current State of Knowledge. Research Report. Justice Policy Center. Washington, DC: Urban Institute; 2002.Available at:www.urban.org. Accessed June 20, 2009.
16. Prochaska JO. Population treatment for addictions. Curr Direct Psycholog Sci. 2004;13:242-246.
17. Hammett TM, Harmon P, Maruschak L. Update: HIV/AIDS, STDs and TB in Correctional Facilities. Washington, DC: US Department of Justice, National Institute of Justice; 1996-1997.
18. Colon HM, Robles RR, Canino G, Sahai H. Prevalence and correlates of DSM-IV substance use disorders in Puerto Rico. Bol Asoc Med PR. 2002;93:12-22.
19. Andrews G, Peters L. The psychometric properties of the Composite International. Soc Psychiatry Psychiatr Epidemiol. 1998;2:80-88.
20. Hanlon TE, Nurco DN, Kinlock TW, Duszynski KR. Trends in criminal activity and drug use over an addiction career. Am J Drug Alcohol Abuse. 1990;16:223-238.
21. Davidson JR, Tharwani HM, Connor KM. Davidson Trauma Scale (DTS): normative scores in the general population and effect sizes in placebo-controlled SSRI trials. Depress Anxiety. 2002;15:75-78.
22. González-Rodríguez R. Neuropsychological and Self Report Evaluation of ADHD in Puerto RIcan Adults: A Pilot Study. San Juan, Carlos Albizu University; 2007.
23. Hershberger SL, Fisher DG, Archuletta E, Rodriguez J. Psychometric characteristics of the English and Spanish language versions of the SOCRATES-8S. Presented at theXVInternationalAIDS Conference; Bangkok, Thailand; July 11-16, 2004.
24. Center for Substance Abuse Treatment (CSAT). Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Treatment Improvement Protocol (TIP) Series 43. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2005. DHHS Publication No. (SMA) 05-4048.
25. Albizu-García C, Román-Badenas L, Caraballo- Correa G, Rivera S, Hernández-Viver AD, Caraballo JN. Estudio de Necesidades de Tratamiento para el Uso de Sustancias y la Prevención de VIH y Hepatitis B/C en las Prisiones de Puerto Rico. San Juán: Report to the Department of Correction and Rehabilitation; 2005.
26. Greenfield SF, Brooks AJ, Gordon SM, et al. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend. 2007;86:1-21.
27. Sullivan LE, Fiellin DA. Hepatitis C and HIV infections: implications for clinical care in injection drug users. Am J Addict. 2004;13:1-20.
28. Bruce RD, Kresina TF, McCance-Katz EF. Medication-assisted treatment and HIV/AIDS: aspects in treating HIV-infected drug users. AIDS. 2010;24:331-340.
29. Brady TM, Krebs CP, Laird G. Psychiatric comorbidity and not completing jail based substance abuse treatment. Am J Addict. 2004;13:83-101.